requirement for dynein function and intact microtubule cytoskeleton for normal surface expression of cardiac potassium channels. Am J Physiol Heart Circ Physiol 296: H71-H83, 2009. First published October 31, 2008 doi:10.1152/ajpheart.00260.2008-Potassium channels at the cardiomyocyte surface must eventually be internalized and degraded, and changes in cardiac potassium channel expression are known to occur during myocardial disease. It is not known which trafficking pathways are involved in the control of cardiac potassium channel surface expression, and it is not clear whether all cardiac potassium channels follow a common pathway or many pathways. In the present study we have surveyed the role of retrograde microtubule-dependent transport in modulating the surface expression of several cardiac potassium channels in ventricular myocytes and heterologous cells. The disruption of microtubule transport in rat ventricular myocytes with nocodazole resulted in significant changes in potassium currents. A-type currents were enhanced 1.6-fold at ϩ90 mV, rising from control densities of 20.9 Ϯ 2.8 to 34.0 Ϯ 5.4 pA/pF in the nocodazole-treated cells, whereas inward rectifier currents were reduced by one-third, perhaps due to a higher nocodazole sensitivity of Kir channel forward trafficking. These changes in potassium currents were associated with a significant decrease in action potential duration. When expressed in heterologous human embryonic kidney (HEK-293) cells, surface expression of Kv4.2, known to substantially underlie A-type currents in rat myocytes, was increased by nocodazole, by the dynein inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride, and by p50 overexpression, which specifically interferes with dynein motor function. Peak current density was 360 Ϯ 61.0 pA/pF in control cells and 658 Ϯ 94.5 pA/pF in cells overexpressing p50. The expression levels of Kv2.1, Kv3.1, human ether-a-go-go-related gene, and Kir2.1 were similarly increased by p50 overexpression in this system. Thus the regulation of potassium channel expression involves a common dynein-dependent process operating similarly on the various channels.
. Because they are responsible for determining the durations of the action potential and refractory period (13, 24) , minor differences in K ϩ currents can have dramatic effects on cellular electrophysiology. The functioning of these channels at the cell surface may be modulated by phosphorylation and other modifications and by association with accessory subunits acting as chaperones (KChIP, KChAP, ␤-subunits; reviewed in Ref. 25) . Regulation also occurs at the level of gene expression (11, 32, 36) and channel assembly (20, 42) and by controls on trafficking to and from the plasma membrane (31) . All of these activities must be coordinated, not only for the regulation of individual channel expression but also to maintain appropriate ratios between channel types. Yet, the regulation and coordination of the expression of these potassium channels remains poorly understood. It is not clear whether most cardiac potassium channels follow a common trafficking pathway or whether they follow multiple pathways that differ from channel to channel.
Newly synthesized potassium channels must traffic from the endoplasmic reticulum, through the Golgi apparatus, and on to the cell surface. Once inserted into the plasma membrane, the channels are sooner or later internalized and targeted for either degradation or recycling to the cell surface. There is considerable evidence that tyrosine phosphorylation events modulate internalization of at least some channels. For Kv1. 2 , this has been directly demonstrated (26) , and there is circumstantial evidence that the same is true for Kv1.3 and Kv1.5 (6, 14) . Internalization has been shown to be dynamin dependent (3, 26) and influenced by the dynein motor function (3) .
Our group (3) has previously reported that interference with dynein function by overexpression of p50/dynamitin causes a marked increase in the surface expression of Kv1.5, the voltage-gated potassium channel that underlies I Kur in the human and canine atrium (7) . We found that this increase in Kv1.5 expression was due to interference with endocytosis of the channel and depended on the presence of a specific SH3-binding domain in the Kv1.5 NH 2 terminus. It remained unknown, however, whether interference with dynein function affects only Kv1.5 or whether the expression of other potassium channels is similarly modified if retrograde trafficking is blocked. We therefore initiated a survey of the effects of interference with microtubule-dependent trafficking on a number of potassium channels that are expressed in the heart.
We presently report the results of that survey, conducted in rat ventricular myocytes and in heterologous cells. In ventric-ular myocytes, we have shown that disruption of the microtubule-dependent transport system by nocodazole causes an increase in I to current density and a reduction in inward rectifier current (I K1 ) density. These changes were reflected in significant differences in action potential duration. We have shown further, in heterologous cells, that expression of Kv4.2, underlying I to1 , is increased both by disruption of the microtubule cytoskeleton and by inhibition of dynein motor function by treatment with erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) and by p50 overexpression. We also have found that p50 overexpression similarly increases Kv2.1, Kv3.1, and hERG functional expression, as well as that of Kir2.1. Potassium channels thus appear to share common trafficking mechanisms. This commonality, also shared with the ClC-2 chloride channel (4), may allow for coordinate regulation of channel expression at the cell surface.
MATERIALS AND METHODS
Cell preparation and transfection. Human embryonic kidney (HEK-293) cells were cultured and transfected as described previously (7) . Transfections were by a liposome-mediated method. One day before transfection, cells were plated on a coverslip in 35-mm dishes at 40 -50% confluence. After 1 day's growth, transfections were performed using 1.5 g of each relevant plasmid and Lipofectamine 2000 transfection reagent (Invitrogen) according to the manufacturer's instructions.
Plasmid constructs. Human p50 in pEGFP was a gift from Richard Vallee (Columbia University, NY). All channel constructs used in this study were cloned into the pcDNA3 vector. Plasmid DNA was prepared for transfection using the Qiagen Plasmid midi kit (Qiagen, Valencia, CA).
Electrophysiological experiments and solutions. Solutions and methodology for the recording of ionic currents were as previously reported from our laboratory (7) . The standard bath solution contained (in mM) 135 NaCl, 5 KCl, 1 MgCl 2, 2.8 sodium acetate, 10 HEPES, and 1 CaCl2, adjusted to pH 7.4 using NaOH. The standard pipette filling solution contained (in mM) 130 KCl, 5 EGTA, 1 MgCl2, 10 HEPES, 4 Na2ATP, and 0.1 GTP, adjusted to pH 7.2 with KOH. All chemicals were obtained from Sigma (Mississauga, ON, Canada). Whole cell current recording and data analysis were done using an Axopatch 200B amplifier and pClamp 9 software (Axon Instruments, Foster City, CA). Patch electrodes were fabricated using thin-walled borosilicate glass (World Precision Instruments, Sarasota, FL) and polished by heating. Pipette resistances were between 1 and 3 M⍀. Compensation for capacitance and series resistance was performed manually in all whole cell recordings. All recordings were performed at room temperature (20 -23°C) .
Myocyte isolation and electrophysiology. All animal use protocols were approved by the Animal Care Committee of the University of British Columbia in accordance with Canadian Institutes of Health Research guidelines. Rat ventricular myocytes were isolated from hearts of male Wistar rats weighing 250 -300 g by using a conventional hanging heart Langendorff apparatus. Rapidly beating hearts were excised from pentobarbital sodium-anesthetized rats, previously dosed with 400 units of heparin via an intraperitoneal injection and hung in fewer than 3 min. The hanging heart was then perfused with Joklik MEM (Sigma-Aldrich) solution containing 24 mM NaHCO 3, 1.2 mM MgSO4, and 1 mM D,L-carnitine, gassed with 95% O2 and 5% CO2. Perfusion pressures started between ϳ10 and 30 mmHg, with top pressures between ϳ80 and 120 mmHg, which were usually reached within 10 min after addition of 165 U/ml type II collagenase (Worthington, Lakewood, NJ), 1 mg/ml fatty acid-free BSA, and 1.6 M CaCl 2. These pressures were usually obtained with a flow rate of 8 ml/min. Once pressures returned to the starting pressure, after ϳ20 min, the ventricle was cut from the heart, minced, and filtered. Cells were equilibrated to 1 mM calcium through three gradual sedimentation steps. Cells were then incubated for 12 h with 35 M nocodazole or vehicle control (0.1% DMSO) at 37°C in M-199 (Sigma-Aldrich) defined medium containing 25 mM HEPES, 10 mg/ml fatty-acid free BSA, 0.6 g/ml insulin, and 1 mM D,L-carnitine on laminin-coated coverslips. Penicillin G (0.6 mM) and 0.1 mM streptomycin were added to prevent bacterial growth over the 12 h. After treatment, cells were rinsed and placed in recording solution containing (in mM) 135 NaCl, 5 KCl, 1 MgCl 2, 2.8 sodium acetate, 10 HEPES, and 1 CaCl2, adjusted to pH 7.4 using NaOH. The pipette filling solution contained (in mM) 130 KCl, 5 EGTA, 1 MgCl 2, 10 HEPES, 4 Na2ATP, and 0.1 GTP, adjusted to pH 7.2 with KOH. In all experiments, control and treated groups of myocytes were prepared in parallel from the same batches of isolated myocytes.
Imaging. For studies of the effects of nocodazole on rat ventricular myocytes, myocytes were treated with 35 M nocodazole (Sigma) for 12 h and then fixed and immunolabeled as previously described (7) . Myocytes were stained with anti-Kv4.2 from Alomone Labs (Jerusalem, Israel). Cells were prepared for imaging according to previously published methods (30) . Briefly, the cells were rinsed and fixed with 4% paraformaldehyde for 12 min at room temperature (RT). After three 5-min washes with 1ϫ phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2HPO4, and 1.4 mM KH2PO4), cells were incubated in a permeabilizing/blocking solution (PBS containing 2% BSA and 0.2% Triton X-100) for 30 min at RT. An affinity-purified rabbit antibody to Kv4.2 was diluted (1:1,000) in blocking solution and incubated with the cells for 2 h at RT. The cells were washed three times for 5 min in PBS on a rotator before incubation with secondary antibody, Alexa488-conjugated goat antirabbit IgG antibody (1:1,000; Molecular Probes) for 1 h on the rotator at RT. Coverslips were then washed three times with PBS before being mounted with 10 l of a 90% glycerol-2.5% (wt/vol) 1,4-diazabicyclo[2.2.2]octane-PBS solution. Images were collected on an Olympus Fluoview 1000 laser scanning confocal microscope equipped with a ϫ60 (NA 1.4) oil-immersion objective. For analysis of membrane region peak fluorescence intensities, images were produced using identical acquisition settings. Pixels outside the membrane region were deleted from the resultant images, and pixel intensities of the plasma membrane regions were determined using the histogram function in ImageJ software (NIH, Bethesda, MD).
Biotinylation and proteinase K sensitivity experiments. For biotinylation experiments, cells were cotransfected with the channel clone and either green fluorescent protein (GFP) or GFP-tagged p50. Surface proteins were biotinylated 24 h later using Pierce EZ-Link sulfo-NHS-LC-biotin per the manufacturer's instructions, and after cell lysis, protein assay, and extraction on streptavidin-coated beads, biotinylated protein was directly subjected to 7.7% SDS-PAGE. Biotinylated channel was detected by the appropriate anti-channel antibody. After incubation with horseradish peroxidase-conjugated secondary antibody, protein bands were visualized using Western Lightning Chemiluminescence Reagent Plus (PerkinElmer Life Sciences) and detected on X-ray film. In proteinase K sensitivity experiments, digestion of surface proteins in living HEK-293 cells was conducted as described by Manganas et al. (21) . Briefly, HEK-293 cells expressing the relevant channel alone or the channel plus p50 were washed and then treated with 200 g/ml proteinase K for 30 min. After extensive washing to remove residual proteinase K, the cells were lysed and processed for Western blot analysis. Antibodies to Kv4.2, Kv3.1, and hERG were obtained from Alomone Labs. Antibody to Kv2.1 was obtained from Antibodies Incorporated (Davis, CA).
RESULTS
Disruption of the microtubule cytoskeleton alters potassium currents in rat ventricular myocytes. As a starting point in surveying the effects of interference with retrograde trafficking on potassium channel expression, we expanded our investigation to rat ventricular myocytes. Previous work had been restricted to atrial myocytes, and it was important to ascertain whether similar processes were operative in the ventricle as well. To test whether any currents in ventricular myocytes were affected by nocodazole treatment, we conducted experiments on freshly isolated rat ventricular myocytes exposed to nocodazole for 12 h. Comparison of current profiles from untreated and nocodazole-treated ventricular myocytes identified at least two currents affected by this interference with microtubule-dependent trafficking. The transient A-type potassium current was substantially enhanced, and inward rectifier currents were attenuated. Figure 1A shows sample A-type potassium current traces from control rat ventricular myocytes and from myocytes treated with nocodazole. An increased A-type current was clearly evident in the nocodazole-treated myocytes. This increase is quantitated in Fig. 1B , where I to is plotted against membrane voltage. I to current density at ϩ90 mV was 20.9 Ϯ 2.8 pA/pF in control myocytes and 34.0 Ϯ 5.4 pA/pF in nocodazole-treated cells. Activation and inactivation kinetics were unaffected (Fig. 1C) , indicating that the changes in the current profile were due to changes in channel functional availability at the plasma membrane. Unlike our previously reported results with atrial myocytes (3), no increase in the sustained current was detected in these ventricular myocytes (Fig. 1F) .
Nocodazole did, however, have a significant effect on inward currents in these myocytes. Inward currents at Ϫ120 mV were reduced by roughly 40%, from Ϫ14.4 Ϯ 2.6 to Ϫ8.99 Ϯ 0.78 pA/pF (Fig. 1, D and E) . This was very different from the increase in currents that we saw with other channels. Nocodazole-resistant microtubules have been reported in several cell types, including rat neonatal cardiomyocytes (39) . Perhaps the difference between the effects of the drug on A-type and inward rectifier currents lies in differential dependence on nocodazole-resistant and nocodazole-sensitive microtubule populations for trafficking in the myocytes. We hypothesized, therefore, that the reduction in inward currents might be due to a higher sensitivity of inward rectifier (Kir) channel forward trafficking to nocodazole relative to that of voltage-gated (Kv) channels. If the hypothesis is correct, block of retrograde trafficking could not increase Kir expression because no new channels would be incorporated in the plasma membrane.
Colchicine treatment reduces both I K1 and I to currents in ventricular myocytes. To gain preliminary insight into whether the reduced inward current could be due to a failure of forward trafficking, we attempted to treat rat ventricular myocytes with B: mean peak current densities (ϮSE) from cells preincubated with nocodazole or vehicle alone at 37°C. *P Ͻ 0.05. C: steady-state activation and inactivation kinetics were unchanged by nocodazole treatment. Activation kinetics were determined from cells held at Ϫ90 mV and depolarized to between Ϫ120 and ϩ90 mV in 10-mV, 500-ms steps, followed by a depolarizing pulse to ϩ60 mV for 100 ms to determine inactivation kinetics. D: inward currents from rat ventricular myocytes treated at 37°C with 35 M nocodazole or vehicle (0.1% DMSO) alone. Representative current traces shown are from Ϫ120 to Ϫ30 mV in 10-mV steps, with the holding potential set at Ϫ90 mV. E: mean steady-state inward current densities (ϮSE) from cells preincubated with nocodazole or vehicle alone at 37°C. *P Ͻ 0.05. F: mean sustained current density-voltage relationship at the end of the 500-ms pulse from cells preincubated with nocodazole or vehicle alone at 37°C. Experimental protocol was as indicated in A.
high concentrations of nocodazole to increase the likelihood of complete microtubule depolymerization. Unfortunately, due to poor solubility, the drug frequently precipitated when added to the bath. To circumvent this problem, we employed colchicine instead. Colchicine is another potent microtubule-depolymerization agent that is frequently used in the study of microtubule-based trafficking. A 1 M solution of this drug has been reported to be sufficient to completely depolymerize microtubules in living cardiomyocytes (34) . The results of these experiments are presented in Fig. 2 .
Similarly to nocodazole, colchicine reduced I K1 by ϳ50% to Ϫ7.7 Ϯ 0.6 pA/pF compared with Ϫ17.1 Ϯ 2.6 pA/pF in the controls (Fig. 2, A and B) . Significantly, and in contrast to the results obtained using nocodazole ( Fig. 1) , colchicine treatment reduced I to in these myocytes, as well (Fig. 2, C and D) . Peak current density at ϩ90 mV fell to 14.1 Ϯ 2.2 pA/pF in colchicine-treated cells from control levels of 28.2 Ϯ 4.9 pA/pF. Activation and inactivation kinetics were unchanged by the drug (Fig. 2E ). We further investigated this phenomenon in HEK-293 cells and found that specific inhibition of retrograde trafficking increased the functional expression of all channels tested, including Kir2.1 (see below).
Nocodazole treatment reduces action potential duration in rat ventricular myocytes. Whatever the basis of the differing effects of nocodazole on I to and I K1 , it was important to determine whether the changes in these currents had any consequences for myocyte functioning. The effects of nocodazole on action potential duration (APD) in rat ventricular myocytes were therefore assayed. Action potential tracings were obtained from current-clamped myocytes pulsed at 2 Hz, 30 times, to reach a steady state for measurement. As shown in Fig. 3A , nocodazole treatment caused a significant shortening of APD. Peak action potential was not affected (Fig. 3E ), but the duration at all repolarization levels was substantially shortened by nocodazole (Fig. 3, B-D) . Measured at 50% repolarization, the duration was approximately halved, falling to 49.8 Ϯ 9.3 ms in nocodazole-treated myocytes from 104.9 Ϯ 20.5 ms in control cells (Fig. 3D) . The reduction in APD was even greater at 10% repolarization, where nocodazole reduced APD by over 60% (Fig. 3D) , but was somewhat weaker at 90% repolarization, where only a 40% reduction of APD was seen (Fig. 3B) . Thus the effect was most prominent early in the repolarization, where the A-type current is more important. Nocodazole had no effect on myocyte membrane capacitance (Fig. 3F ). All told, these data demonstrate that the increased voltage-gated potassium channel expression associated with nocodazole treatment has significant physiological effects.
Disruption of dynein function increases Kv4.2 surface expression in myocytes and heterologous cells. The A-type current in rat ventricular myocytes is reportedly underlain by Representative current traces shown are from Ϫ120 to Ϫ30 mV in 10-mV steps, with the holding potential set at Ϫ90 mV. B: mean steady-state inward current densities (ϮSE) from cells preincubated with colchicine or vehicle alone at 37°C. C: representative current traces from rat ventricular myocytes treated at 37°C with 1 M colchicine or vehicle (0.1% DMSO) alone for 12 h. Traces shown are from Ϫ60 mV in 10-mV steps to ϩ 90 mV, from a holding potential of Ϫ90 mV. D: mean peak current densities (ϮSE) from cells preincubated with colchicine or vehicle alone at 37°C. *P Ͻ 0.05. E: steady-state activation and inactivation kinetics were unchanged by colchicine treatment. Activation kinetics were determined from cells held at Ϫ90 mV and depolarized to between Ϫ120 and ϩ90 mV in 10-mV, 500-ms steps, followed by a depolarizing pulse to ϩ60 mV for 100 ms to determine inactivation kinetics. *P Ͻ 0.05. Kv4.2 and Kv4.3 (12, 18, 24, 40) . To confirm the involvement of Kv4.2 in the nocodazole-induced increase in A-type currents, we performed immunocytochemistry. Freshly isolated myocytes were treated with nocodazole or vehicle and then fixed, permeabilized, and labeled with rabbit anti-Kv4.2 and Alexa488-labeled goat anti-rabbit secondary antibody. As shown in Fig. 4A , Kv4.2 expression at or near the cell surface was increased in nocodazole-treated cells relative to controls, as shown by the higher level of punctate and intercalated disk staining in these cells compared with controls. Mean peak fluorescence signal intensity at or near the cell surface, quantitated using NIH ImageJ software, was significantly higher in nocodazole-treated cells than in control cells, at 76.9 Ϯ 4.5 and 56.4 Ϯ 5.7 pixel intensity units, respectively (P Ͻ 0.01; Student's t-test) (Fig. 4B) .
Previous work showed that nocodazole-induced increases in atrial myocyte and heterologous cell K ϩ currents were related to a failure in normal retrograde trafficking of the channel tested, Kv1.5 (3). Inhibition of the dynein motor by p50 overexpression increased Kv1.5 currents in heterologous cells to the same extent as nocodazole, and the two treatments were not additive. p50 is a component of the dynactin complex and is an essential link between the dynein motor and its cargointeracting subunits. When p50 is overexpressed, it causes the dynactin complex to dissociate, decoupling the motor from its cargo (5) .
Because overexpression of p50 in cardiomyocytes is difficult to achieve, we extended our work to heterologous HEK-293 cells. Unlike myocytes, HEK-293 cells can be readily transfected and experimental effects on individual channel isoforms can be investigated. Of particular value for these studies, retrograde trafficking can be specifically blocked by transfection with p50, the overexpression of which, as mentioned above, blocks dynein motor function. As a first test of whether Kv4.2 expression was increased by block of retrograde trafficking in HEK-293 cells, surface biotinylation experiments were performed. As shown in Fig. 4C (first and third lanes) , biotinylation experiments using HEK-293 cells expressing Kv4.2 demonstrated that in these cells, too, the amount of Kv4.2 resident at the cell surface was increased by nocodazole. Densitometric analysis indicated that this increase was 2.06 Ϯ 0.37-fold higher relative to control (n ϭ 4, P Ͻ 0.05). p50 overexpression (expressed as a GFP fusion in pEGFP) also increased Kv4.2 surface expression in these cells, indicating involvement of the dynein motor in this phenomenon. The optical density of the Kv4.2 band was 1.60 Ϯ 0.17-fold higher in the lanes loaded with extracts from p50-overexpressing cells relative to control (n ϭ 6, P Ͻ 0.05). Figure 4D (second lane) shows that p50 overexpression was robust in this system, much higher, in fact, than that of unfused EGFP expressed in the control and nocodazole-treated cells. Control experiments measuring transferrin receptor biotinylation from the same samples (Fig. 4E) showed that another membrane protein was similarly biotinylated.
Nocodazole and inhibition of dynein motor function increase Kv4.2 currents in heterologous cells. Electrophysiological experiments yielded data consistent with the biotinylation results. Nocodazole treatment of HEK-293 cells expressing Kv4.2 substantially increased potassium current densities in these cells. Peak current density at ϩ90 mV was increased from 267 Ϯ 48.3 pA/pF in control cells to 420 Ϯ 45.6 pA/pF in the nocodazole-treated cells (Fig. 5, A and B) . The pharmacological dynein motor inhibitor EHNA (4) also produced an increase in Kv4.2 expression. Kv4.2 currents were roughly doubled by a 6-h treatment with 100 M EHNA (Fig. 5, C and  D) . At ϩ90 mV, peak current density in EHNA-treated cells was 398 Ϯ 85.6 pA/pF, much higher than the 201 Ϯ 35.4 pA/pF in cells treated with vehicle alone (P Ͻ 0.05). Overexpression of p50 to interfere with dynein function yielded similar results, confirming an important role for the dynein motor in the normal modulation of Kv4.2 expression. Peak current density in control cells at ϩ90 mV was 360 Ϯ 61.0 pF/pA, whereas that in the p50-overexpressing cells was 658 Ϯ 94.5 pA/pF (Fig. 6, A and B) . Interestingly, it took time for p50 overexpression to exert its effect. When assayed at 12 to 24 h posttransfection, no effect of p50 on Kv4.2 currents was evident (Fig. 6, C and D) . p50 expression was robust in the first 12-24 h posttransfection (data not shown). Perhaps prolonged exposure to a substantial concentration of p50 is required to sufficiently block dynein function in this system. Changes in channel kinetics played no role in the increased currents seen in any of these experiments. Neither Kv4.2 steady-state activation nor inactivation was affected by p50 overexpression or nocodazole treatment (Fig. 7, A and B) . These kinetic results were comparable to those obtained with the ventricular myocytes (Fig. 1C) . Activation was slightly right shifted in EHNA-treated cells (Fig. 7C ) but because it would act to decrease peak currents at each voltage, this rightward shift cannot account for the increased Kv4.2 currents associated with incubation with this dynein inhibitor.
New channel synthesis is not responsible for the increase in Kv4.2 currents. One alternative explanation for the increase in Kv4.2 currents associated with p50 overexpression is that p50 is somehow causing an increase in delivery of newly synthe- (2°) antibody (Alexa488-conjugated goat anti-rabbit) but without primary (1°) antibody. B: membrane region peak pixel fluorescence intensities. All images were produced using identical acquisition settings. Pixels outside the membrane region were deleted from the resultant images, and pixel intensities of the plasma membrane regions were determined using the histogram function in ImageJ. **P Ͻ 0.01 compared with vehicle control. C: p50 overexpression or treatment with 35 M nocodazole increases surface Kv4.2 expression in HEK-293 cells. Cells were cotransfected with Kv4.2 and either green fluorescent protein (GFP) or GFP-tagged p50 (p-50-GFP). Surface proteins were biotinylated 48 h later, and after cell lysis and protein assay, biotinylated protein was isolated on streptavidin beads and subjected to Western blot analysis using an anti-Kv4.2 antibody. Noc, nocodazole. D: whole cell lysates were run on SDS-PAGE and probed with anti-GFP to detect GFP or p50-GFP. E: Western blot analysis of the same samples used in C probed for transferrin receptor. Mouse anti-human transferrin receptor (Zymed Laboratories) was used as the primary antibody.
sized channel to the cell surface. To test this possibility, we treated control and p50-transfected cells expressing Kv4.2 with 100 g/ml cycloheximide for 6 h before patch clamping. Cycloheximide blocks protein synthesis and thus should deprive the cell of new channels that could be inserted into the plasma membrane. Indicating that new synthesis is not required for the increase in Kv4.2 currents induced by p50 overexpression, cycloheximide treatment had no influence on this increase (Fig. 8) . In control cells, p50 increased Kv4.2-associated peak current densities to 613.4 Ϯ 60.1 pA/pF at ϩ90 mV in cells overexpressing p50 from the baseline 452.7 Ϯ 42.7 pA/pF at ϩ90 mV in cells coexpressing GFP alone (Fig. 8, A and B) . Current densities in cycloheximidetreated cells coexpressing GFP alone were significantly lower . From a holding potential of Ϫ90 mV, cells were depolarized to between Ϫ120 and ϩ90 mV in 10-mV steps for 500 ms, followed by depolarization to ϩ60 mV for 100 ms. *P Ͻ 0.05. C: representative traces from HEK-293 cells transiently expressing Kv4.2 and treated for 6 h with 100 M EHNA or vehicle control. D: peak current densities (ϮSE) from HEK-293 cells transiently expressing Kv4.2 and treated for 6 h with 100 M EHNA or vehicle control. *P Ͻ 0.05. From a holding potential of Ϫ90 mV, cells were depolarized to between Ϫ120 and ϩ90 mV in 10-mV steps for 500 ms, followed by depolarization to ϩ60 mV for 100 ms. B: peak current densities (ϮSE) from HEK-293 cells transiently expressing Kv4.2 36 -48 h after transfection with GFP or p50-GFP. *P Ͻ 0.05. C: representative currents from HEK-293 cells transiently expressing Kv4.2 12-24 h after transfection with GFP or p50-GFP. From a holding potential of Ϫ90 mV, cells were depolarized to between Ϫ120 and ϩ90 mV in 10-mV steps for 500 ms, followed by depolarization to ϩ60 mV for 100 ms. D: peak current densities (ϮSE) from HEK-293 cells stably expressing Kv4.2 12-24 h after transfection with GFP or p50-GFP. *P Ͻ 0.05. than in control, at 267.1 Ϯ 33.1 pA/pF at ϩ90 mV (P Ͻ 0.01), but cycloheximide treatment was completely ineffective in blocking the increase in Kv4.2-expressing cells overexpressing p50 (Fig. 8, C and D) . Peak current densities in these cells averaged 620.1 Ϯ 82.8 pA/pF at ϩ90 mV, a value indistinguishable from that measured in their cohorts untreated with cycloheximide (see above). Activation and inactivation kinetics were not affected by cycloheximide treatment (Fig. 9) . Thus disruption of dynein function increases Kv4.2 surface expression by a mechanism independent of new channel synthesis.
Effects of p50 overexpression on additional voltage-gated potassium channels. The findings that surface expression of both Kv1.5 (3) and Kv4.2 are increased by p50 overexpression suggests that the expression of other potassium channels also may be increased by interference with dynein motor function; that is, retrograde trafficking may be important to the mainte- Fig. 7 . p50/dynamitin and nocodazole have no effect on Kv4.2 channel kinetics. A: steady-state activation and inactivation from HEK-293 cells transiently expressing Kv4.2 36 -48 h after transfection with control vector (GFP) or p50-GFP. Cells were held at Ϫ90 mV and depolarized to between Ϫ120 and ϩ90 mV in 10-mV, 500 ms steps, followed by a depolarizing pulse to ϩ60 mV for 100 ms. B: steady-state activation and inactivation from HEK-293 cells transiently transfected with Kv4.2 36 -48 h before treatment for 8 h with 35 M nocodazole or vehicle (0.1% DMSO). Cells were held at Ϫ90 mV and depolarized to between Ϫ120 and ϩ90 mV in 10-mV, 500-ms steps, followed by a depolarizing pulse to ϩ60 mV for 100 ms. C: steady-state activation and inactivation from HEK-293 cells transiently transfected with Kv4.2 36 -48 h before treatment for 6 h with 100 M EHNA or vehicle (0.1% DMSO). Cells were held at Ϫ90 mV and depolarized to between Ϫ120 and ϩ90 mV in 10-mV, 500-ms steps, followed by a depolarizing pulse to ϩ60 mV for 100 ms. Fig. 8 . Cycloheximide reduces control Kv4.2 currents but does not block increase in currents associated with p50 overexpression. A: representative traces from HEK-293 cells transiently expressing Kv4.2 36 -48 h after transfection with control empty vector (GFP) before treatment for 6 h with 100 g/ml cycloheximide or vehicle alone (0.1% DMSO). Cells were held at Ϫ90 mV and depolarized to between Ϫ120 and ϩ90 mV in 10-mV, 500-ms steps, followed by a depolarizing pulse to ϩ60 mV for 100 ms. B: peak current densities (ϮSE) from HEK-293 cells transiently expressing Kv4.2 36 -48 h after transfection with GFP and before treatment described in A. *P Ͻ 0.05. C: representative currents from HEK-293 cells transiently expressing Kv4.2 36 -48 h after transfection with p50-GFP and before treatment described in A. D: peak current densities from HEK-293 cells stably expressing Kv4.2 36 -48 h after transfection with p50-GFP and before treatment described in A.
nance of normal concentrations of many channels at the cell surface. To test this hypothesis, we investigated the effects of p50 overexpression on additional potassium channels.
Kv2.1, like Kv1.5, contributes to delayed rectifier currents in rat and mouse heart (1, 2, 19) . It is an important contributor to the delayed rectifier current in rat hippocampal neurons (22) and is apparently involved in oxygen sensing in some cell types (27) . As shown in Fig. 10, A and B , overexpression of p50 significantly increased Kv2.1 currents. Current densities increased from 610 Ϯ 110 pA/pF in control cells to 920 Ϯ 120 pA/pF at ϩ80 mV in cells transfected with the p50-GFP construct. Kv2.1 surface expression was also measured using a proteinase K sensitivity assay. When applied externally to living cells, the protease cleaves exposed protein on the exterior of the cell, leaving cytoplasmic proteins unaffected. This assay is a sensitive test for cell surface expression and allows the ready determination of the relative proportions of the channel at the cell surface and in the cytoplasm (20) . A representative result of the proteinase K assay of Kv2.1 surface expression is shown in Fig. 11A . Intact Kv2.1 migrates at Ͼ83 kDa, and the cleaved COOH-terminal fragment detected by the antibody migrates at ϳ30 kDa (Fig. 11A, lanes 2 and 4) . Densitometric analysis of the results of three proteinase K sensitivity assays showed that Kv2.1 surface expression was Fig. 9 . Cycloheximide treatment has no effect on Kv4.2 channel kinetics. A: steady-state activation and inactivation from HEK-293 cells transiently expressing Kv4.2 36 -48 h after transfection with control vector (GFP) and before treatment for 6 h with 100 g/ml cycloheximide or vehicle (0.1% DMSO). Cells were held at Ϫ90 mV and depolarized to between Ϫ120 and ϩ90 mV in 10-mV, 500-ms steps, followed by a depolarizing pulse to ϩ60 mV for 100 ms. B: steady-state activation and inactivation from HEK-293 cells transiently transfected with Kv4.2 and p50 36 -48 h earlier and treated for 6 h with 100 g/ml cycloheximide or vehicle (0.1% DMSO) immediately before patch clamping. Cells were held at Ϫ90 mV and depolarized to between Ϫ120 and ϩ90 mV in 10-mV, 500-ms steps, followed by a depolarizing pulse to ϩ60 mV for 100 ms. We also tested the effect of p50 overexpression on Kv3.1, a channel that has, like Kv1.5 (7), been associated with I Kur in the dog (41) . It also is expressed in neurons (9) and has been implicated in oxygen sensing in pulmonary smooth muscle (27) . As with the other Kv channels tested, we found that p50 Fig. 11 . p50 overexpression increases surface expression of Kv2.1, Kv3.1, and the human ether-a-go-go-related gene product (hERG). Cells were cotransfected with the indicated channel and either GFP or p50-GFP. Proteinase K and surface biotinylation experiments were performed as described in MATERIALS AND METHODS. A: Kv2.1 proteinase K sensitivity. HEK-293 cells were cotransfected with Kv2.1 and either GFP (lanes 1 and 2) or p50-GFP (lanes 3 and 4) and treated with externally applied proteinase K (lanes 2 and 4) or buffer alone (lanes 1 and 3) . The upper arrows indicate the position of the undigested channel in the gel, and the lower arrows indicate the location of the surface Kv2.1 (digested form). B: Kv3.1 proteinase K sensitivity. Experiments were performed as described in A, except that the cells were transfected with Kv3.1 rather than Kv2.1. The dual upper bands are common with Kv3.1 and probably represent differences in the glycosylation states of the channel. C: surface biotinylation of hERG. HEK-293 cells stably expressing hERG were transfected with GFP (lane 1) or p50-GFP (lane 2). Surface proteins were biotinylated 48 h after transfection, and after cell lysis and protein assay, biotinylated protein was isolated on streptavidin beads and subjected to Western blot analysis using an anti-hERG antibody. B: peak tail current densities (ϮSE) from HEK-293 cells stably expressing hERG 36 -48 h after transfection with GFP or p50-GFP. hERG currents were elicited by a 4-s depolarization from a holding potential of Ϫ70 mV in 10-mV steps from Ϫ60 to ϩ40 mV, followed by a 4-s repolarization to Ϫ50 mV. *P Ͻ 0.05. C: representative current traces from HEK-293 cells stably expressing hERG 12-24 h after transfection with GFP or p50-GFP. D: peak tail current densities (ϮSE) from HEK-293 cells stably expressing hERG 12-24 h after transfection with GFP or p50-GFP. hERG currents were elicited by a 4-s depolarization from a holding potential of Ϫ70 mV in 10-mV steps from Ϫ70 to ϩ40 mV, followed by a 4-s repolarization to Ϫ50 mV. overexpression was associated with a marked increase in functional expression of this channel (Fig. 10, C and D) . Current densities were increased from 3.8 Ϯ 0.5 nA/pF in controls to 5.7 Ϯ 0.9 nA/pF at ϩ80 mV in Kv3.1-expressing HEK-293 cells transfected with p50. Proteinase K sensitivity assays also indicated that surface expression of Kv3.1 was increased by the p50 overexpression (Fig. 11B) . Densitometric analysis showed that Kv3.1 expression was 1.71 Ϯ 0.15-fold greater in the p50-overexpressing cells than in the controls (n ϭ 3, paired t-test, P Ͻ 0.05).
hERG expression is also increased by dynein inhibition. We tested the effect of p50 overexpression on a more distantly related voltage-gated potassium channel, hERG. Responsible for I Kr in cardiomyocytes, hERG exhibits kinetics very different from other Kv channels (28, 33) and effectively functions as an inward rectifier. Activation is very slow, but inactivation is rapid as the cell depolarizes. Upon repolarization, hERG recovers from inactivation through the open state, passing the bulk of the current associated with channel activity. hERG is best known because of its association with acquired long QT syndrome. The channel is readily blocked by a wide variety of pharmacological compounds, and their interactions with the channel can lead to the sometimes fatal torsades de pointes arrhythmia (29) .
Surface biotinylation experiments indicated that hERG surface expression was increased by p50 overexpression (Fig.  11C) . Similar to Kv4.2, the optical density of the hERG band was 1.63 Ϯ 0.12-fold higher in the lanes loaded with extracts from p50-overexpressing cells relative to control (n ϭ 3, paired t-test, P Ͻ 0.05). Electrophysiological experiments confirmed this increased surface expression. As shown in Fig. 12, A and B, hERG expression was increased by p50 overexpression when assayed 36 -48 h posttransfection. Peak tail current densities at Ϫ50 mV were 30.8 Ϯ 3.8 pA/pF in control cells and 43.7 Ϯ 3.4 pA/pF in p50-overexpressing cells, respectively (P Ͻ 0.05). Thus interference with dynein function caused increased functional expression of all voltage-gated potassium channels tested. Like Kv4.2, however, this effect on hERG currents took time to develop. At 12-24 h posttransfection, p50 overexpression had no effect on these currents (Fig. 12, C and D) .
Dynein inhibition also increases Kir2.1 expression. As noted above, whereas the transient outward current in rat ventricular myocytes was substantially enhanced by incubation of the cells with nocodazole, the major inward current was dramatically attenuated (Fig. 1) . We hypothesized that this reduction in I K1 might be due to a higher sensitivity of forward trafficking of Kir channels vs. Kv channels to microtubule depolymerization. The finding that colchicine caused reductions in both I K1 and I to (Fig. 2) provided circumstantial evidence consistent with this hypothesis. Because Kir2.1, the major inward rectifier of the rat heart, underlies I K1 , we tested the effects of p50 overexpression on the expression of this channel in heterologous cells. The results of these experiments are presented in Fig. 13, A and B .
In the p50-overexpressing cells, steady-state current density at Ϫ120 mV was Ϫ53.0 Ϯ 11.2 pA/pF, significantly higher than the density of Ϫ17.2 Ϯ 4.9 pA/pF measured in control cells (P Ͻ 0.01). This result demonstrates that the expression of Kir2.1 is increased by inhibition of retrograde trafficking in much the same way as are those of the Kv channels. This result is consistent, too, with the hypothesis that microtubule depolymerization agents reduce inward currents in myocytes via effects on another process, most likely forward trafficking.
DISCUSSION
Our group (3) has previously demonstrated that inhibition of dynein motor function substantially increases surface expression of Kv1.5 in atrial myocytes and in heterologous expression systems. In the present study, we have shown that the A-type current (I to ) in ventricular myocytes, like I Kur in atrial myocytes, is increased by interference with microtubule-dependent trafficking, whereas I K1 is reduced. We also have shown, in heterologous cells, that expression of a channel underlying I to , Kv4.2, is similarly increased by nocodazole treatment and, importantly, that interference with dynein function by EHNA treatment and via p50 overexpression has the same effect. Furthermore, we have surveyed the effects of p50 overexpression on the functional expression of a variety of additional potassium channels. We have found that the expression of Kv2.1, Kv3.1, and hERG are all similarly increased by this interference with dynein function, as is Kir2.1. Thus an intact retrograde trafficking system is important for maintaining normal expression levels of these channels at the cell surface. It is highly likely that dynein motor function is required for the normal modulation of the surface expression of many additional channels. Dhani et al. (4) , for example, have shown that p50 overexpression increases the surface expression of ClC-2 chloride channels, as well.
One explanation for the increased currents seen in most channels when retrograde trafficking is blocked is that internalization of cell-surface expressed channels is stopped or slowed while, concomitantly, newly synthesized channel continues to traffic to the plasma membrane. The possibility that treatment with nocodazole causes similar increases in channel surface expression seems, on first inspection, to be inconsistent with this hypothesis, since the microtubule cytoskeleton is required for both retrograde and anterograde trafficking. However, given that nocodazole-resistant microtubules have been reported and the fact that colchicine treatment caused reductions in I to in the ventricular myocytes, this possibility is consistent with the data to date. Indeed, a failure in forward trafficking is the simplest explanation for the reductions in I K1 seen in both the colchicine-and nocodazole-treated myocytes, especially in light of the fact that specific inhibition of retrograde trafficking by p50 overexpression causes increased expression of Kir2.1.
Another possible explanation for the nocodazole-and p50 overexpression-induced increase in voltage-gated potassium currents is that vesicular pools of internalized voltage-gated channels have been released for reinsertion into the plasma membrane. Block of dynein function does not prevent endocytosis and recycling of early endosomes (35) , and depolymerization of the cortical actin cytoskeleton is known to increase the surface expression of Kv4.2 (38) . The finding that cycloheximide treatment fails to block the p50-induced increase in Kv4.2 currents speaks in favor of this possibility. The released channels may reside in intracellular pools that are routinely available for insertion into the membrane, or they may comprise channels that would normally be targeted for degradation, were intracellular trafficking intact. Kir channels, underlying I K1 , on the other hand, might be internalized into a different compartment unable to recycle to the plasma membrane, or their half-life at the plasma membrane might be much shorter than those of the various Kv channels. Maintenance of normal Kir surface numbers, under such a scenario, would require more robust trafficking of newly synthesized Kir channels to the cell surface than would be required of the recycling Kv channels.
We found no increase in sustained currents in response to nocodazole treatment in the ventricular myocytes. This is in striking contrast to our results with atrial cells (3). Kv1.5, which underlies the increased sustained currents in the atrium, is reportedly not functionally expressed in the ventricle (7, 8) . Perhaps the channels underlying sustained currents in the ventricle are unaffected by perturbation of microtubule-dependent trafficking, or perhaps the expression of some are increased while that of others is decreased, resulting in no net change in the overall current.
The changes in ion channel expression described in this report may have important physiological and therapeutic implications. The changes observed in the ventricular myocytes after microtubule depolymerization were associated with a significant reduction in action potential duration. Clearly, changes in potassium channel trafficking can significantly affect cell function, both electrical, via changes in action potential morphology, and contractile, by altering the balance of Ca 2ϩ entry and exit. There are dramatic changes in cardiac ion channel profiles associated with diseases such as myocardial infarction and congestive heart failure (10, 15, 17, 37) . Conceivably, modulation of dynein function could be at least partially responsible for this cardiac remodeling. Ishibashi et al. (16) have found that a microtubule depolymerization agent can reverse the depression of contractility in ventricular myocytes from rats with pressure overload left ventricular hypertrophy.
From the present work, it is evident that intact retrograde trafficking is important to the regulation of normal Kv channel expression levels. The normal trafficking of internalized voltage-gated potassium channels is clearly dependent on the dynein motor. It will be of great interest to learn whether additional channel types are similarly regulated and whether there are differences in the pathways into which the internalized channels traffic.
